Karin J. Fijnvandraat

Amsterdam, NH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 205 publications

Undetectable Hydroxyurea Levels in the Majority of Sickle Cell Disease Patients, Especially in Young Children.

Undetectable Hydroxyurea Levels in the Majority of Sickle Cell Disease Patients, Especially in Young Children.

Journal: American journal of hematology

Published: June 10, 2026

Thrombin Generation as a Potential Surrogate Marker of Hemostatic Status in the Era of Novel Therapies for Hemophilia.

Thrombin Generation as a Potential Surrogate Marker of Hemostatic Status in the Era of Novel Therapies for Hemophilia.

Journal: Thrombosis and haemostasis

Published: May 12, 2026

A multicenter prospective observational cohort study to improve diagnostic yield and clinical management of persons with a Bleeding Disorder of Unknown Cause (BDUC-iN study protocol).

A multicenter prospective observational cohort study to improve diagnostic yield and clinical management of persons with a Bleeding Disorder of Unknown Cause (BDUC-iN study protocol).

Journal: Research and practice in thrombosis and haemostasis

Published: May 07, 2026

The Diagnosis and Evaluation of Women and Girls with Hemophilia and Hemophilia Carriers: Guidance from the SSC of the ISTH.

The Diagnosis and Evaluation of Women and Girls with Hemophilia and Hemophilia Carriers: Guidance from the SSC of the ISTH.

Journal: Journal of thrombosis and haemostasis : JTH

Published: April 10, 2026

Immunopeptidomics of blood coagulation factor IX: a core peptide derived from the protease domain is promiscuously presented on HLA-DR.

Immunopeptidomics of blood coagulation factor IX: a core peptide derived from the protease domain is promiscuously presented on HLA-DR.

Journal: Research and practice in thrombosis and haemostasis

Published: March 09, 2026

Blood loss due to diagnostic testing in extremely preterm infants in 22 European countries: a prospective observational study.

Blood loss due to diagnostic testing in extremely preterm infants in 22 European countries: a prospective observational study.

Journal: EClinicalMedicine

Published: February 27, 2026

Effect of EMDR for reduction of pain interference in children with sickle cell disease, the RELAX study: a randomized controlled trial protocol.

Effect of EMDR for reduction of pain interference in children with sickle cell disease, the RELAX study: a randomized controlled trial protocol.

Journal: BMC pediatrics

Published: January 23, 2026

Clinical Outcomes of Efanesoctocog Alfa Prophylaxis in Children With Severe Haemophilia A: Interim Data From XTEND-ed.

Clinical Outcomes of Efanesoctocog Alfa Prophylaxis in Children With Severe Haemophilia A: Interim Data From XTEND-ed.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: December 09, 2025

Diagnosis and management of hemophilia A and B.

Diagnosis and management of hemophilia A and B.

Journal: Journal of thrombosis and haemostasis : JTH

Published: November 26, 2025

Effect of Red Blood Cell Transfusion on Inflammatory and Angiogenic Pathways in Patients With Sickle Cell Disease.

Effect of Red Blood Cell Transfusion on Inflammatory and Angiogenic Pathways in Patients With Sickle Cell Disease.

Journal: American journal of hematology

Published: October 20, 2025

Correction: Rewriting the script: gene therapy and genome editing for von Willebrand Disease.

Correction: Rewriting the script: gene therapy and genome editing for von Willebrand Disease.

Journal: Frontiers in genome editing

Published: October 06, 2025

Large deletions in the F8 gene predict immune tolerance induction failure in people with severe hemophilia A.

Large deletions in the F8 gene predict immune tolerance induction failure in people with severe hemophilia A.

Journal: Research and practice in thrombosis and haemostasis

Published: September 30, 2025

Showing 1-12 of 205

Last Updated: 09/26/2026